LeonaBio (LONA) Shares Outstanding (Weighted Average) (2019 - 2026)

LeonaBio (LONA) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $19.0 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $19.0 million, up 387.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.0 million (up 387.34% YoY), and the FY2025 annual result was $5.5 million, up 42.99% from the prior year.
• Shares Outstanding (Weighted Average) grew to $19.0 million in Q1 2026 per LONA's latest filing, from $5.5 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $39.1 million in Q2 2025 and troughed at $3.8 million in Q4 2024.
• A 5-year average of $29.0 million and a median of $37.8 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Weighted Average) sank 89.88% in 2024, then surged 387.34% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $37.7 million in 2022, then rose by 0.76% to $38.0 million in 2023, then slumped by 89.88% to $3.8 million in 2024, then surged by 42.99% to $5.5 million in 2025, then soared by 245.8% to $19.0 million in 2026.
• Business Quant data shows LONA's Shares Outstanding (Weighted Average) at $19.0 million in Q1 2026, $5.5 million in Q4 2025, and $3.9 million in Q3 2025.